DRS

Leonardo DRS, Inc.

62
Fundamentals69/ 100
Valuation56/ 100
Upside potential76/ 100
Risk potential14/ 100

DRS has the edge over RKLB overall, supported by lower modeled downside and stronger modeled upside.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB's outlook is improving, though it still trails on the overall score.

DRS Fundamentals

MetricStatus
Healthy
Healthy
Healthy
Strong

DRS's revenue, profitability, cash flow and balance sheet are all currently healthy.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

DRS PE Valuation

CHEAPFAIREXPENSIVE14x29x43x57x
CHEAPFAIREXPENSIVE14x29x43x57x
LevelPEPriceVs current
Cheap9x$12.28-66%
Forward24x$35.66—
Current26x$35.66—
Fair27x$36.60+2.6%
Expensive43x$58.75+65%

Historical ranges are pointers, not guarantees.

DRS's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

DRS Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Improving
Limited
Moderate

Analysts expect earnings and revenue growth for DRS, with profitability improving.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

DRS Risk to reward

ScenarioChangePrice
Upside+43%$51.09
Downside-14%$30.69

Calculated from the latest close: $35.66 on Nov 12.

DRS has a better modeled risk to reward balance than RKLB, with more potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB trails DRS on modeled risk to reward, with less potential upside relative to its potential downside.

DRS Earnings Per Share

Q4 2023: $0.64Q1 2024: $0.70Q2 2024: $0.71Q3 2024: $0.74Q4 2024: $0.80Q1 2025: $0.88Q2 2025: $0.94Q3 2025: $0.99Q4 2025: $1.03Q1 2026: $1.07Q2 2026: $1.19Q3 2026: $1.36Forward: $1.48
Q4 2023: $0.64Q1 2024: $0.70Q2 2024: $0.71Q3 2024: $0.74Q4 2024: $0.80Q1 2025: $0.88Q2 2025: $0.94Q3 2025: $0.99Q4 2025: $1.03Q1 2026: $1.07Q2 2026: $1.19Q3 2026: $1.36Forward: $1.48
QuarterTTM EPSYoY
Forward$1.48+8.5%
Q3 2026$1.36+37%
Q2 2026$1.19+27%
Q1 2026$1.07+22%
Q4 2025$1.03+29%
Q3 2025$0.99+34%
Q2 2025$0.94+32%
Q1 2025$0.88+26%
Q4 2024$0.80+25%

DRS has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

DRS Quarterly Revenue

Q4 2023: $926MQ1 2024: $688MQ2 2024: $753MQ3 2024: $812MQ4 2024: $981MQ1 2025: $799MQ2 2025: $829MQ3 2025: $960MQ4 2025: $1.1BQ1 2026: $846MQ2 2026: $913MQ3 2026: $1.1B
Q4 2023: $926MQ1 2024: $688MQ2 2024: $753MQ3 2024: $812MQ4 2024: $981MQ1 2025: $799MQ2 2025: $829MQ3 2025: $960MQ4 2025: $1.1BQ1 2026: $846MQ2 2026: $913MQ3 2026: $1.1B
QuarterRevenueYoY
Q3 2026$1.1B+11%
Q2 2026$913M+10%
Q1 2026$846M+5.9%
Q4 2025$1.1B+8.1%
Q3 2025$960M+18%
Q2 2025$829M+10%
Q1 2025$799M+16%
Q4 2024$981M+5.9%

DRS's revenue has grown year over year for 14 quarters in a row: $1.1B last quarter, up 11% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over DRS on sales, with stronger typical year-over-year growth.

DRS Free Cash Flow

Q4 2023: $497MQ1 2024: −$275MQ2 2024: $0Q3 2024: $47MQ4 2024: $414MQ1 2025: −$170MQ2 2025: −$56MQ3 2025: $77MQ4 2025: $376MQ1 2026: −$96MQ2 2026: $6MQ3 2026: $58M
Q4 2023: $497MQ1 2024: −$275MQ2 2024: $0Q3 2024: $47MQ4 2024: $414MQ1 2025: −$170MQ2 2025: −$56MQ3 2025: $77MQ4 2025: $376MQ1 2026: −$96MQ2 2026: $6MQ3 2026: $58M
QuarterFree cash flowYoY
Q3 2026$58M-25%
Q2 2026$6M+$62M
Q1 2026-$96M+$74M
Q4 2025$376M-9.2%
Q3 2025$77M+64%
Q2 2025-$56M-$56M
Q1 2025-$170M+$105M
Q4 2024$414M-17%

DRS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

DRS Total Shares

Q4 2023: 264MQ1 2024: 266MQ2 2024: 267MQ3 2024: 268MQ4 2024: 268MQ1 2025: 269MQ2 2025: 269MQ3 2025: 268MQ4 2025: 269MQ1 2026: 269MQ2 2026: 269MQ3 2026: 268M
Q4 2023: 264MQ1 2024: 266MQ2 2024: 267MQ3 2024: 268MQ4 2024: 268MQ1 2025: 269MQ2 2025: 269MQ3 2025: 268MQ4 2025: 269MQ1 2026: 269MQ2 2026: 269MQ3 2026: 268M
PeriodChange %Net change
Quarterly-0.2%-600K shares
1 year0%-100K shares
3 years+1.2%+3.3M shares
5 years+85%+123M shares
Available history+85%+123M shares

DRS has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

DRS Net Leverage

Q4 2023: -0.2xQ1 2024: 0.7xQ2 2024: 0.6xQ3 2024: 0.5xQ4 2024: -0.6xQ1 2025: -0.0xQ2 2025: 0.2xQ3 2025: 0.1xQ4 2025: -0.7xQ1 2026: -0.4xQ2 2026: -0.2xQ3 2026: -0.2x
Q4 2023: -0.2xQ1 2024: 0.7xQ2 2024: 0.6xQ3 2024: 0.5xQ4 2024: -0.6xQ1 2025: -0.0xQ2 2025: 0.2xQ3 2025: 0.1xQ4 2025: -0.7xQ1 2026: -0.4xQ2 2026: -0.2xQ3 2026: -0.2x
QuarterNet LeverageStatus
Q3 2026-0.2xNet Cash
Q2 2026-0.2xNet Cash
Q1 2026-0.4xNet Cash
Q4 2025-0.7xNet Cash
Q3 20250.1xVery low
Q2 20250.2xVery low
Q1 2025-0.0xNet Cash
Q4 2024-0.6xNet Cash

DRS has more cash than debt.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

DRS Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic21.1Neutral

DRS's weekly RSI is 42 (neutral) and its Stochastic is 21 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

DRS PE vs Industrials Sector

MetricDRSSector medianRelative
PE26x24x8.9% above
PE %49589 pts below

DRS is trading at 26x earnings, in line with the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

DRS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$35.90.8% below
20 week MA$39.710% below
50 week MA$41.013% below
100 week MA$39.810% below
200 week MA$30.417% above

DRS has fallen below most of its moving averages, though it's still 17% above its 200-week average.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB has the edge over DRS on trend strength, trading above more of its moving averages.

DRS Yearly ROI

YearStart priceEnd priceROI
2020$5.35$10.3+92%
2021$10.3$9.45-8%
2022$9.45$13.2+39%
2023$13.2$20.0+52%
2024$20.0$32.5+62%
2025$32.5$34.3+5.3%
2026 YTD$34.3$35.7+4%

DRS has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key